Möchten Sie immer auf dem neuesten Stand bleiben?

DENVER, May 01, 2026 (GLOBE NEWSWIRE) -- Liberty Global Ltd. announces its Q1 2026 financial results. CEO Mike Fries stated, “In the first quarter, we made continued progress against our...

NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will...

Xos, Inc. (NASDAQ: XOS) to release Q1 2026 financial results & host earnings call on May 14, 2026 at 4:30 PM ET. Webcast available.

NEWPORT BEACH, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CV Holdings, Inc. (OTC Pink Limited: CVHL) (the “Company”) today reported a net loss for the year ended December 31, 2025 of $(16,241,821)...

BOSTON, April 30, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and...

CHARLOTTE, N.C., April 30, 2026 (GLOBE NEWSWIRE) -- SPX Technologies, Inc. (NYSE:SPXC) (“SPX”, the “Company”, “we” or “our”) today reported results for the first quarter ended March 28, 2026. First...

Financial Highlights† Reported revenue of $381.9 million, up 7%Constant currency revenue* and constant currency revenue, organic* up 5% and up 3%, respectively Constant currency revenue, organic*...

AUVELITY is a first-in-class treatment, which targets the NMDA and sigma-1 receptors, approved for agitation associated with dementia due to Alzheimer’s disease  The safety and tolerability profile...

AVITA Medical appoints Cary Vance as President and CEO following interim tenure; Jan Stern Reed named Board Chair

AUSTIN, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce...